Karyotypic pattern of pancreatic adenocarcinomas correlates with survival and tumour grade
Corresponding Author
Bertil Johansson
Department of Clinical Genetics, Odense University, Odense, Denmark
Department of Clinical Genetics, Odense University, Odense, DenmarkSearch for more papers by this authorGeorgia Bardi
Department of Medical Genetics, Odense University, Odense, Denmark
Search for more papers by this authorNikos Pandis
Department of Medical Genetics, Odense University, Odense, Denmark
Search for more papers by this authorLudmila Gorunova
Department of Clinical Genetics, Odense University, Odense, Denmark
Search for more papers by this authorPia Lena Bäckman
Department of Surgery, Odense University, Odense, Denmark
Search for more papers by this authorNils Mandahl
Department of Clinical Genetics, Odense University, Odense, Denmark
Search for more papers by this authorSigmund Dawiskiba
Department of Surgery, Odense University, Odense, Denmark
Clinical Pathology and Cytology, University Hospital, S-221 85 Lund, Sweden
Search for more papers by this authoråke Andrén-Sandberg
Department of Surgery, Odense University, Odense, Denmark
Search for more papers by this authorSverre Heim
Department of Clinical Genetics, Odense University, Odense, Denmark
Department of Medical Genetics, Odense University, Odense, Denmark
Search for more papers by this authorFelix Mitelman
Department of Clinical Genetics, Odense University, Odense, Denmark
Search for more papers by this authorCorresponding Author
Bertil Johansson
Department of Clinical Genetics, Odense University, Odense, Denmark
Department of Clinical Genetics, Odense University, Odense, DenmarkSearch for more papers by this authorGeorgia Bardi
Department of Medical Genetics, Odense University, Odense, Denmark
Search for more papers by this authorNikos Pandis
Department of Medical Genetics, Odense University, Odense, Denmark
Search for more papers by this authorLudmila Gorunova
Department of Clinical Genetics, Odense University, Odense, Denmark
Search for more papers by this authorPia Lena Bäckman
Department of Surgery, Odense University, Odense, Denmark
Search for more papers by this authorNils Mandahl
Department of Clinical Genetics, Odense University, Odense, Denmark
Search for more papers by this authorSigmund Dawiskiba
Department of Surgery, Odense University, Odense, Denmark
Clinical Pathology and Cytology, University Hospital, S-221 85 Lund, Sweden
Search for more papers by this authoråke Andrén-Sandberg
Department of Surgery, Odense University, Odense, Denmark
Search for more papers by this authorSverre Heim
Department of Clinical Genetics, Odense University, Odense, Denmark
Department of Medical Genetics, Odense University, Odense, Denmark
Search for more papers by this authorFelix Mitelman
Department of Clinical Genetics, Odense University, Odense, Denmark
Search for more papers by this authorAbstract
The relationship between cytogenetic findings and clinico-histopathological parameters was assessed in 29 patients with pancreatic adenocarcinoma. Karyotypic analysis revealed normal karyotypes (N) in 8 carcinomas and abnormal karyotypes (A) in 21. Within the A group, 8 cases had simple chromosome abnormalities (As), i.e., only one numerical or structural aberration, whereas 13 had complex changes with multiple numerical and structural abnormalities (Ac). No significant differences between the N and A groups were detected in terms of tumour grade, clinical stage, type of surgery performed, tumour site or size or the patient's age and survival. A correlation analysis between groups As and Ac revealed a significant difference with regard to grade, poorly differentiated carcinomas being more frequent in the Ac group. Patients in the Ac group had also a significantly shorter survival time than those in the As group. None of the other potentially prognostic parameters, i.e., grade, tumour site, stage and type of surgery performed, correlated significantly with clinical outcome. © 1994 Wiley-Liss, Inc.
References
- Arthur, D. C., Berger, R., Golomb, H. M., and 16 others. The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet. Cytogenet., 40, 203–216 (1989).
-
Bardi, G.,
Johansson, B.,
Pandis, N.,
Bak-Jensen, E.,
Örndal, C.,
Heim, S.,
Mandahl, N.,
Andrén-Sandberg, Å. and
Mitelman, F.,
Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathologic features.
Cancer,
71,
306–314
(1993a)
10.1002/1097-0142(19930115)71:2<306::AID-CNCR2820710207>3.0.CO;2-C CAS PubMed Web of Science® Google Scholar
- Bardi, G., Johansson, B., Pandis, N., Mandahl, N., Bak-Jensen, E., Andrén-Sandberg, A. R., Mitelman, F. and Heim, S., Karyotypic abnormalities in tumours of the pancreas. Brit. J. Cancer, 67, 1106–1112 (1993b).
- Bardi, G., Johansson, B., Pandis, N., Mandahl, N., Bak-Jensen, E., Lindström, C, Törnqvist, A., Frederiksen, H., Andrén-Sandberg, Å., Mitelman, F. and Heim, S., Cytogenetic analysis of 52 colorectal carcinomas—non-random aberration pattern and correlation with pathologic parameters. Int. J. Cancer, 55, 422–428 (1993).
- Eskelinen, M., Lipponen, P., Marin, S., Haapasalo, H., Mäkinen, K., Ahtola, H., Puittinen, J., Nuutinen, P. and Alhava, E., Prognostic factors in human pancreatic cancer, with special reference to quantitative histology. Scand. J. Gastroenterol., 26, 483–490 (1991).
- Falor, W. H. and Ward-Skinner, R. M., The importance of marker chromosomes in superficial transitional cell carcinoma of the bladder: 50 patients followed up to 17 years. J. Urol., 139, 929–932 (1988).
- Grünewald, K., Lyons, J., Fröhlich, A., Feichtinger, H., Weger, R. A., Schwab, G., Janssen, J. W. G. and Bartram, C. R., High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int. J. Cancer, 43, 1037–1041 (1989).
-
Gudjonsson, B.,
Cancer of the pancreas. 50 years of surgery.
Cancer,
60,
2284–2303
(1987).
10.1002/1097-0142(19871101)60:9<2284::AID-CNCR2820600930>3.0.CO;2-V CAS PubMed Web of Science® Google Scholar
-
Hayashi, Y.,
Kanda, N.,
Inaba, T.,
Hanada, R.,
Nagahara, N.,
Muchi, H. and
Yamamoto, K.,
Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1.
Cancer,
63,
126–132
(1989).
10.1002/1097-0142(19890101)63:1<126::AID-CNCR2820630120>3.0.CO;2-Z CAS PubMed Web of Science® Google Scholar
- Heim, S., Mandahl, N., Jin, Y., Strömblad, S., Lindström, E., Salford, L. G. and Mitelman, F., Trisomy 7 and sex chromosome loss in human brain tissue. Cytogenet. Cell Genet., 52, 136–138 (1989).
- ISCN, Guidelines for Cancer Cytogenetics. In: F. Milelman (ed.), Supplement to an international system for human cytogenetic nomenclature. S. Karger, Basel (1991).
-
Johansson, B.,
Bardi, G.,
Heim, S.,
Mandahl, N.,
Mertens, F.,
Bak-Jensen, E.,
Andrén-Sandbkrg, Å. and
Mitelman, F.,
Nonrandom chromosomal rearrangements in pancreatic carcinomas.
Cancer,
69,
1674–1681
(1992).
10.1002/1097-0142(19920401)69:7<1674::AID-CNCR2820690706>3.0.CO;2-L CAS PubMed Web of Science® Google Scholar
- Johansson, B., Heim, S., Mandahl, N., Mertens, F. and Mitllman, F., Trisomy 7 in nonneoplastic cells. Genes Chromosomes Cancer, 6, 199–205 (1993).
- Kimmel, D. W., O'Fallon, J. R., Scheithauer, B. W., Kelly, P. J., Dewald, G. W. and Jenkins, R. B., Prognostic value of cytogenetic analysis in human cerebral astrocytomas. Ann. Neural., 31, 534–542 (1992).
- Klöppel, G. and Maillet, B., Classification and staging of pancreatic nonendocrine tumors. Radiol. Clin. North Amer., 27, 105–119 (1989).
- Lundgren, R., Heim, S., Mandahl, N., Anderson, H. and Mitelman, F., Chromosome abnormalities are associated with unfavorable outcome in prostatic cancer patients. J. Urol., 147, 784–788 (1992).
- Offit, K., Chromosome analysis in the management of patients with non-Hodgkin's lymphoma. Leukemia Lymphoma, 7, 275–282 (1992).
- Pejovic, T., Himmelmann, A., Heim, S., Mandahl, N., Flodérus, U.-M., Furgyik, S., Elmfors, B., Helm, G., Willén, H. and Mitelman, F., Prognostic impact of chromosome aberrations in ovarian cancer. Brit. J. Cancer, 65, 282–286 (1992).
-
Porschen, R.,
Remy, U.,
Bevers, G.,
Schauseil, S.,
Hengels, K.-J. and
Borchard, F.,
Prognostic significance of DNA ploidy in adenocar-cinoma of the pancreas. A flow cytometric study of paraffin-embedded specimens.
Cancer,
71,
3846–3850
(1993).
10.1002/1097-0142(19930615)71:12<3846::AID-CNCR2820711209>3.0.CO;2-I CAS PubMed Web of Science® Google Scholar
- Pui, C.-H. and Crist, W. M., Cytogenetic abnormalities in childhood acute lymphoblastic leukemia correlates with clinical features and treatment outcome. Leukemia Lymphoma, 7, 259–274 (1992).
- Tiainen, M., Tammilehto, L., Rautonen, J., Tuomi, T., Mattson, K. and Knuutila, S., Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma. Brit. J. Cancer, 60, 618–626 (1989).
- Trent, J. M., Meyskens, F. L., Salmon, S. E., Ryschon, K., Leong, S. P. L., Davis, J. R.. and McGee, D. L., Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma. New Engl J. Med., 322, 1508–1511 (1990).
- UICC, P. Hermanek and L. H. Sobin, (eds.), TNM classification of malignant tumors, 4th ed., Springer, Berlin (1987).